Medlab Clinical Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Net Income	-7.23	-7.16	-12.32
Depreciation & Amortization	0.85	0.85	0.87
Share-Based Compensation	0.08	0.08	0.62
Other Operating Activities	-3.11	-3.11	0.56
Operating Cash Flow	-9.41	-9.41	-10.35
Capital Expenditures	-0.03	-0.03	-0.08
Other Investing Activities	1.78	1.78	-
Investing Cash Flow	1.74	1.74	-0.08
Share Issuance / Repurchase	-	-	15.45
Debt Issued / Paid	-0.57	-0.57	-0.64
Financing Cash Flow	-0.57	-0.57	14.81
Net Cash Flow	-8.24	-8.24	4.38
Free Cash Flow	-9.44	-9.44	-10.43
Free Cash Flow Margin	-614.57%	-614.57%	-1423.78%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).